We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.5B
AUM Growth
+$7.34M
Cap. Flow
-$73M
Cap. Flow %
-4.88%
Top 10 Hldgs %
46.64%
Holding
137
New
2
Increased
21
Reduced
46
Closed
6

Top Buys

Rank Stock Value
1
DKNG icon
DraftKings
DKNG
+$6.2M
2
ISRG icon
Intuitive Surgical
ISRG
+$5.72M
3
PYPL icon
PayPal
PYPL
+$5.68M
4
DLR icon
Digital Realty Trust
DLR
+$3.45M
5
AKAM icon
Akamai
AKAM
+$1.58M

Top Sells

Rank Stock Value
1
STX icon
Seagate
STX
+$9.55M
2
IBM icon
IBM
IBM
+$7.48M
3
JNPR
Juniper Networks
JNPR
+$5.93M
4
AMZN icon
Amazon
AMZN
+$5.62M
5
MSFT icon
Microsoft
MSFT
+$5.25M

Sector Composition

Rank Sector Weight
1 Technology 38.39%
2 Healthcare 16.16%
3 Consumer Discretionary 15.09%
4 Communication Services 14.33%
5 Financials 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
51
Intuitive Surgical
ISRG
$127B
$6.8M 0.45%
28,740
+25,470
+779% +$5.72M
AIZ icon
52
Assurant
AIZ
$13.9B
$5.38M 0.36%
44,350
VRTX icon
53
Vertex Pharmaceuticals
VRTX
$123B
$5.21M 0.35%
19,140
+60
+0.3% +$16.6K
BIIB icon
54
Biogen
BIIB
$30.9B
$4.9M 0.33%
17,273
-3,050
-15% -$851K
PAYX icon
55
Paychex
PAYX
$43.4B
$4.75M 0.32%
59,535
-4,695
-7% -$353K
BNY
56
Bank of New York Mellon
BNY
$103B
$4.45M 0.3%
129,525
-1,005
-0.8% -$36.6K
SEDG icon
57
SolarEdge
SEDG
$2.37B
$4.17M 0.28%
17,490
-2,000
-10% -$384K
DGX icon
58
Quest Diagnostics
DGX
$26B
$3.52M 0.23%
30,700
-10,000
-25% -$1.18M
CRL icon
59
Charles River Laboratories
CRL
$11.3B
$3.16M 0.21%
13,965
-3,150
-18% -$654K
STX icon
60
Seagate
STX
$174B
$3.1M 0.21%
62,813
-203,355
-76% -$9.55M
UNH icon
61
UnitedHealth
UNH
$382B
$2.88M 0.19%
9,250
JKHY icon
62
Jack Henry & Associates
JKHY
$11.4B
$2.59M 0.17%
15,915
+1,600
+11% +$278K
TRV icon
63
Travelers Companies
TRV
$81.1B
$2.3M 0.15%
21,288
-42,980
-67% -$4.93M
NVO
64
Novo Nordisk
NVO
$228B
$2.25M 0.15%
64,920
UTHR icon
65
United Therapeutics
UTHR
$26.1B
$2.21M 0.15%
21,885
+7,480
+52% +$821K
SNY icon
66
Sanofi
SNY
$107B
$2.18M 0.15%
43,380
EG icon
67
Everest Group
EG
$15.6B
$2.09M 0.14%
10,600
MRK icon
68
Merck
MRK
$322B
$1.97M 0.13%
24,880
ELV icon
69
Elevance Health
ELV
$81.5B
$1.92M 0.13%
7,155
DIOD icon
70
Diodes
DIOD
$3.5B
$1.84M 0.12%
32,640
+970
+3% +$49.1K
CRUS icon
71
Cirrus Logic
CRUS
$6.76B
$1.84M 0.12%
27,240
+7,840
+40% +$491K
COHU icon
72
Cohu
COHU
$1.86B
$1.78M 0.12%
103,636
KLIC icon
73
Kulicke & Soffa
KLIC
$4.34B
$1.73M 0.12%
77,140
+18,495
+32% +$437K
SYK icon
74
Stryker
SYK
$135B
$1.71M 0.11%
8,210
AEIS icon
75
Advanced Energy
AEIS
$10.1B
$1.7M 0.11%
26,980
+4,000
+17% +$279K

Similar funds

Oak Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Oak Associates held 137 positions worth $1.5B, up 0.49% from $1.49B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Oak Associates withdrew a net $73M in Q3 2020, closing 6 positions and reducing 46 holdings. Its most notable exit was Capital One, an estimated $5.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Oak Associates opened a new position in DraftKings worth $9.38M.

  • Oak Associates's largest Q3 2020 buy was DraftKings: 159,505 shares worth $9.38M.
  • Oak Associates added most to Intuitive Surgical in Q3 2020, an estimated $5.72M increase.
  • Oak Associates's biggest Q3 2020 reduction was Seagate, cutting an estimated $9.55M.
  • Oak Associates fully exited Capital One in Q3 2020, selling an estimated $5.11M.
  • Oak Associates's ten largest holdings make up 47% of its $1.5B portfolio in Q3 2020.
  • Oak Associates opened 2 new positions and closed 6 in Q3 2020.
  • Oak Associates's portfolio value rose 0.49% quarter-over-quarter to $1.5B.

Based on Oak Associates's 13F filing for Q3 2020, filed 13 Nov 2020.